Biopharmaceutical companies stand to benefit from digital transformation, particularly by using artificial intelligence to analyze and apply manufacturing and supply chain data, write experts from Deloitte. "The ability to adjust processes and track medications in real time will allow biopharma companies to manage their supply, quality, safety, security and costs, resulting in more intelligent manufacturing and supply chain decision-making," they write.